Your browser doesn't support javascript.
loading
Factors associated with the prevalence of neonatal abstinence syndrome in West Virginia.
Rogerson, Taylor; Houston, Anthony; Lyman, Garrett; Ogden, Jenna; Paschall, Kevin; Penaranda, Mark; Rios, Alexandria; Wetzel, Robert; Horzempa, Joseph.
Afiliação
  • Rogerson T; Department of Graduate Health Sciences, West Liberty University, West Liberty, West Virginia.
  • Houston A; Department of Graduate Health Sciences, West Liberty University, West Liberty, West Virginia.
  • Lyman G; Department of Graduate Health Sciences, West Liberty University, West Liberty, West Virginia.
  • Ogden J; Department of Graduate Health Sciences, West Liberty University, West Liberty, West Virginia.
  • Paschall K; Department of Graduate Health Sciences, West Liberty University, West Liberty, West Virginia.
  • Penaranda M; Department of Graduate Health Sciences, West Liberty University, West Liberty, West Virginia.
  • Rios A; Department of Graduate Health Sciences, West Liberty University, West Liberty, West Virginia.
  • Wetzel R; Department of Graduate Health Sciences, West Liberty University, West Liberty, West Virginia.
  • Horzempa J; Department of Graduate Health Sciences, West Liberty University, West Liberty, West Virginia; Department of Natural Sciences and Mathematics, West Liberty University, West Liberty, West Virginia.
J Opioid Manag ; 14(6): 445-452, 2018.
Article em En | MEDLINE | ID: mdl-30629281
Neonatal abstinence syndrome (NAS) is a group of problems associated with withdrawal symptoms of a newborn who was exposed to maternal opiate use while in the womb. West Virginia (WV) is of utmost concern as this state exhibits among the highest rates of opioid abuse and consequently, NAS. In this manuscript, we review factors associated with the prevalence of NAS in WV. We provide evidence suggesting that states exhibiting high Medicaid participation demonstrate a high NAS rate, further associating these two factors. Although a similar trend was observed in the substate geographic regions of WV, the presence of regional treatment facilities was negatively associated with NAS prevalence in WV, possibly suggesting that the establishment and utilization of more of these facilities may reduce NAS. Future research investigating factors that contribute to NAS is essential for the elimination of this syndrome.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Assunto principal: Síndrome de Abstinência Neonatal / Transtornos Relacionados ao Uso de Substâncias / Analgésicos Opioides / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans / Newborn País/Região como assunto: America do norte Idioma: En Revista: J Opioid Manag Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Assunto principal: Síndrome de Abstinência Neonatal / Transtornos Relacionados ao Uso de Substâncias / Analgésicos Opioides / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans / Newborn País/Região como assunto: America do norte Idioma: En Revista: J Opioid Manag Ano de publicação: 2018 Tipo de documento: Article